Skip to Main content
New interface

Export Publications

Export the displayed publications:
Number of documents


Curriulum vitae Schvoerer Evelyne

Journal articles73 documents

  • Cédric Hartard, Ahlam Chaqroun, Nicla Settembre, Guillaume Gauchotte, Benjamin Lefevre, et al.. Multiorgan and Vascular Tropism of SARS-CoV-2. Viruses, 2022, 14 (3), pp.515. ⟨10.3390/v14030515⟩. ⟨hal-03765141⟩
  • Anne Gégout-Petit, Hélène Jeulin, Karine Legrand, Nicolas Jay, Agathe Bochnakian, et al.. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France. Viruses, 2021, 13 (6), pp.1076. ⟨10.3390/v13061076⟩. ⟨hal-03269207⟩
  • M. Varbanov, I. Bertrand, S. Philippot, C. Retourney, M. Gardette, et al.. Somatic coliphages are conservative indicators of SARS-CoV-2 inactivation during heat and alkaline pH treatments. Science of the Total Environment, 2021, 797, pp.149112. ⟨10.1016/j.scitotenv.2021.149112⟩. ⟨hal-03338452⟩
  • Isabelle Bertrand, Julie Challant, Helene Jeulin, Cédric Hartard, Laurence Mathieu, et al.. Epidemiological surveillance of SARS-CoV-2 by genome quantification in wastewater applied to a city in the northeast of France: Comparison of ultrafiltration- and protein precipitation-based methods. International Journal of Hygiene and Environmental Health, 2021, 233, pp.113692. ⟨10.1016/j.ijheh.2021.113692⟩. ⟨hal-03167302⟩
  • Cédric Hartard, Honorine Fenaux, Alexis Gentilhomme, John Murray, Elma Akand, et al.. Variability in molecular characteristics of Hepatitis E virus quasispecies could modify viral surface properties and transmission. Journal of Viral Hepatitis, 2021, 28 (7), pp.1078-1090. ⟨10.1111/jvh.13513⟩. ⟨hal-03338461⟩
  • F Goehringer, A Tiotiu, Evelyne Schvoerer, R Jaussaud, B Hoen. Maraviroc, a future treatment of sarcoidosis? An unexpected drug effect. Journal of Investigational Allergology and Clinical Immunology, 2020, 31 (1), ⟨10.18176/jiaci.0537⟩. ⟨hal-03065385⟩
  • Abderrahim Oussalah, Stanislas Gleye, Isabelle Clerc Urmes, Elodie Laugel, Françoise Barbé, et al.. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. EClinicalMedicine, 2020, 27, pp.100554. ⟨10.1016/j.eclinm.2020.100554⟩. ⟨hal-03065397⟩
  • Anaëlle Muggeo, Corentine Alauzet, Cédric Hartard, Antoine Goury, Evelyne Schvoerer, et al.. Co-detection of SARS-CoV-2 and other respiratory pathogens: Lessons from the field to face the second wave. Journal of Clinical Virology, 2020, 133, pp.104658. ⟨10.1016/j.jcv.2020.104658⟩. ⟨hal-03053923⟩
  • Raphaël Kormann, Audrey Jacquot, Asma Alla, Alice Corbel, Matthieu Koszutski, et al.. Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury. Clinical Kidney Journal, 2020, 13 (3), pp.362-370. ⟨10.1093/ckj/sfaa109⟩. ⟨hal-03065394⟩
  • Abderrahim Oussalah, Stanislas Gleye, Isabelle Clerc-Urmès, Elodie Laugel, Jonas Callet, et al.. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France. Clinical Infectious Diseases, 2020, 71 (9), pp.2447-2456. ⟨10.1093/cid/ciaa677⟩. ⟨hal-02930284⟩
  • Elodie Laugel, Cédric Hartard, Helene Jeulin, Sibel Berger, Véronique Venard, et al.. Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E viruses. Reviews in Medical Virology, 2020, ⟨10.1002/rmv.2197⟩. ⟨hal-03149680⟩
  • H. Fenaux, M. Chassaing, Sébastien Berger, C. Gantzer, I. Bertrand, et al.. Transmission of hepatitis E virus by water: An issue still pending in industrialized countries. Water Research, 2019, 151, pp.144-157. ⟨10.1016/j.watres.2018.12.014⟩. ⟨hal-02014228⟩
  • Morgan Faivre, Vanessa Cottet, Jean-Baptiste Bour, Carine Richou, Séverine Valmary-Degano, et al.. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis. Journal of Clinical Gastroenterology, 2019, 53 (3), pp.236-241. ⟨10.1097/MCG.0000000000001039⟩. ⟨hal-03182481⟩
  • Cédric Hartard, C. Gantzer, Jean‐pierre Bronowicki, Evelyne Schvoerer. Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge. Reviews in Medical Virology, 2019, 29 (6), pp.328-340. ⟨10.1002/rmv.2078⟩. ⟨hal-02921758⟩
  • Morgan Faivre, Vanessa Cottet, Jean-Baptiste Bour, Carine Richou, Séverine Valmary-Degano, et al.. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis. Journal of Clinical Gastroenterology, In press, 53 (3), pp.236-241. ⟨10.1097/MCG.0000000000001039⟩. ⟨hal-01978375⟩
  • Audrey Jacquot, Charles-Edouard Luyt, Antoine Kimmoun, Bruno Levy, Elisabeth Baux, et al.. Epidemiology of post-influenza bacterial pneumonia due to Panton–Valentine leucocidin positive Staphylococcus aureus in intensive care units: a retrospective nationwide study. Intensive Care Medicine, 2019, 45 (9), pp.1312-1314. ⟨10.1007/s00134-019-05665-3⟩. ⟨hal-03065415⟩
  • Helene Jeulin, Eliette Jeanmaire, John Murray, Brice Malve, Marie André, et al.. Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort. Journal of Clinical Virology, 2019, 120, pp.27-32. ⟨10.1016/j.jcv.2019.08.010⟩. ⟨hal-03065402⟩
  • H. Fenaux, M. Chassaing, Sébastien Berger, H. Jeulin, A. Gentilhomme, et al.. Molecular features of Hepatitis E Virus circulation in environmental and human samples. Journal of Clinical Virology, 2018, 103, pp.63 - 70. ⟨10.1016/j.jcv.2018.04.003⟩. ⟨hal-01901546⟩
  • L Lambert-Niclot, C Grude, L. Chaix, L Charpentier, C Reigadas, et al.. Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study). Journal of Antimicrobial Chemotherapy, 2018, 73 (8), pp.2147 - 2151. ⟨10.1093/jac/dky142⟩. ⟨hal-01899927⟩
  • Marine Eschlimann, Brice Malve, Aurélie Velay, Honorine Fenaux, Sibel Berger, et al.. The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection. Journal of Clinical Virology, 2017, 94, pp.115-122. ⟨10.1016/j.jcv.2017.08.001⟩. ⟨hal-01903775⟩
  • Brice Malve, Marine Eschlimann, Shaunagh Galgey, Honorine Fenaux, Fabien Zoulim, et al.. Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution. Virus Research, 2017, 238 (3), pp.141-147. ⟨10.1016/j.virusres.2017.06.028⟩. ⟨hal-02014270⟩
  • Sophie Lafontaine, Christine Prin-Mathieu, Aurélie Velay, Odette Agulles, Evelyne Schvoerer, et al.. Evaluation of Virological Microparticle Enzyme Immunoassay According to the ISO 15189: Real-Life Experience in a University Hospital.. Clinical Laboratory, 2016, 62 (3), pp.275-84. ⟨10.7754/clin.lab.2015.150214⟩. ⟨hal-02014290⟩
  • A. Velay, H. Jeulin, M. Eschlimann, B. Malvé, F. Goehringer, et al.. Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy. Journal of Viral Hepatitis, 2016, 23 (5), pp.387-398. ⟨10.1111/jvh.12498⟩. ⟨hal-01482132⟩
  • Abderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, Céline Chery, Rosa-Maria Guéant, et al.. BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease. Oncotarget, 2016, 8 (38), pp.62842-62857. ⟨10.18632/oncotarget.11327⟩. ⟨hal-01494359⟩
  • Alexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, Jérôme Boursier, Viorica Balan, et al.. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. Journal of Gastroenterology and Hepatology, 2016, 31 (10), pp.1750 - 1756. ⟨10.1111/jgh.13338⟩. ⟨hal-01482298⟩
  • Pierre Frange, Pierre Assoumou, Diane Descamps, Antoine Chéret, Cécile Goujard, et al.. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies. Journal of Antimicrobial Chemotherapy, 2015, 70 (7), pp.2084-2089. ⟨10.1093/jac/dkv049⟩. ⟨hal-01983697⟩
  • Cathia Soulié, Diane Descamps, Vé Ronique Schneider, Mary-Anne Trabaud, Laurence Morand-Joubert, et al.. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma. Journal of Antimicrobial Chemotherapy, 2015, 70 (2), pp.566-572. ⟨10.1093/jac/dku419⟩. ⟨hal-02291062⟩
  • François Habersetzer, Rémy Moenne-Loccoz, Nicolas Meyer, Evelyne Schvoerer, Pauline Simo-Noumbissie, et al.. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection. Liver International, 2015, 35 (1), pp.130-139. ⟨10.1111/liv.12661⟩. ⟨hal-01488141⟩
  • Sylvie Larrat, Sophie Vallet, Sandra David-Tchouda, Alban Caporossi, Jennifer Margier, et al.. Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin. Journal of Clinical Microbiology, 2015, 53 (7), pp.2195-2202. ⟨10.1128/JCM.03633-14⟩. ⟨hal-02014295⟩
  • H. Jeulin, M. Foissac, L. Boyer, Nelly Agrinier, Pascale Perrier, et al.. Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France. Journal of Antimicrobial Chemotherapy, 2014, 69 (11), pp.3095-3102. ⟨10.1093/jac/dku256⟩. ⟨hal-01484261⟩
  • John Murray, Rémy Moenne-Loccoz, Aurélie Velay, François Habersetzer, Michel Doffoel, et al.. Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks. PLoS ONE, 2013, 8 (6), pp.e67254. ⟨10.1371/journal.pone.0067254⟩. ⟨hal-02014327⟩
  • Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, Antoine Chaillon, Sophie Pakianather, et al.. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. Journal of Antimicrobial Chemotherapy, 2013, 68 (11), pp.2626-2631. ⟨10.1093/jac/dkt238⟩. ⟨hal-02291004⟩
  • Sophie Vallet, Sylvie Larrat, Syria Laperche, Hélène Le Guillou-Guillemette, Florence Legrand-Abravanel, et al.. Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.. Journal of Clinical Microbiology, American Society for Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩. ⟨hal-00935958⟩
  • Hélène Jeulin, Aurélie Velay, John Murray, Evelyne Schvoerer. Clinical impact of hepatitis B and C virus envelope glycoproteins. World Journal of Gastroenterology, 2013, 19 (5), pp.654-664. ⟨10.3748/wjg.v19.i5.654⟩. ⟨hal-01481003⟩
  • Evelyne Schvoerer, Rémy Moenne-Loccoz, John Murray, Aurélie Velay, Marine Turek, et al.. Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization. Journal of Infectious Diseases, 2013, 207 (8), pp.1306-1315. ⟨10.1093/infdis/jit032⟩. ⟨hal-02014345⟩
  • Sophie Vallet, Florent Viron, Cécile Henquell, Hélène Le Guillou-Guillemette, Gisèle Lagathu, et al.. NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1–5. Antiviral Therapy, 2011, 16 (7), pp.1093-1102. ⟨10.3851/IMP1900⟩. ⟨hal-02014349⟩
  • Cécile Henquell, Julien Guglielmini, Jannick Verbeeck, Antoine Mahul, Vincent Thibault, et al.. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infection, Genetics and Evolution, 2011, 11 (2), pp.496-503. ⟨10.1016/j.meegid.2010.12.015⟩. ⟨hal-02014356⟩
  • Syria Laperche, Françoise Bouchardeau, Vincent Thibault, Anne-Marie Roque-Afonso, Pascale Trimoulet, et al.. Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits. Journal of Clinical Microbiology, 2011, 49 (3), pp.1113-1115. ⟨10.1128/JCM.01511-10⟩. ⟨hal-02014377⟩
  • R. Moenne-Loccoz, C. Razafinjatovo, F. Habersetzer, A. Ananna, M. Doffoel, et al.. Tropisme leucocytaire du virus de l’hépatite C – intérêt de l’analyse des séquences des gènes des glycoprotéines d’enveloppe virales E1 et E2. Pathologie Biologie, 2010, 58 (2), pp.170-174. ⟨10.1016/j.patbio.2009.06.010⟩. ⟨hal-02014419⟩
  • N. Bouzgarrou, E. Hassen, S. Gabbouj, E. Schvoerer, N. Ben Mami, et al.. Lack of effect of tumor necrosis factor-alpha-308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2010, 34 (4-5), pp.297-304. ⟨10.1016/j.gcb.2010.03.008⟩. ⟨pasteur-01375285⟩
  • Rebecca Pastor, François Habersetzer, Samira Fafi-Kremer, Michel Doffoel, Thomas-F Baumert, et al.. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.. World Journal of Gastroenterology, 2009, 15 (6), pp.753-5. ⟨hal-02043721⟩
  • N. Bouzgarrou, E. Hassen, W. Mahfoudh, S. Gabbouj, E. Schvoerer, et al.. NS5A(ISDR-V3) Region Genetic Variability of Tunisian HCV-1b Strains: Correlation With the Response to the Combined Interferon/Ribavirin Therapy. Journal of Medical Virology, 2009, 81 (12), pp.2021-2028. ⟨10.1002/jmv.21641⟩. ⟨pasteur-01375327⟩
  • C Mello, C. Thumann, Evelyne Schvoerer, E. Soulier, P Pinho, et al.. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation. Journal of Viral Hepatitis, 2009, 16 (10), pp.732-737. ⟨10.1111/j.1365-2893.2009.01125.x⟩. ⟨hal-02014453⟩
  • Florence Legrand-Abravanel, Philippe Colson, Helene Le Guillou-Guillemette, Laurent Alric, Isabelle Ravaux, et al.. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.. Journal of Medical Virology, Wiley-Blackwell, 2009, 81 (12), pp.2029. ⟨10.1002/jmv.21583⟩. ⟨hal-00531821⟩
  • Frédéric Schramm, Eric Soulier, Cathy Royer, Thierry Weitten, Samira Fafi‐kremer, et al.. Frequent Compartmentalization of Hepatitis C Virus with Leukocyte‐Related Amino Acids in the Setting of Liver Transplantation. Journal of Infectious Diseases, 2008, 198 (11), pp.1656-1666. ⟨10.1086/592986⟩. ⟨hal-02014476⟩
  • S. Fafi-Kremer, M.B. Zeisel, Evelyne Schvoerer, E. Soulier, F. Habersetzer, et al.. Anticorps neutralisants dirigés contre le virus de l’hépatite C. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2008, 32 (5), pp.491-498. ⟨10.1016/j.gcb.2008.02.026⟩. ⟨hal-02014491⟩
  • N. Bouzgarrou, E. Hassen, E. Schvoerer, F. Stoll-Keller, O. Bahri, et al.. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. Journal of Medical Virology, 2008, 80 (4), pp.607 - 614. ⟨10.1002/jmv.21079⟩. ⟨pasteur-01375203⟩
  • C. Thumann, Evelyne Schvoerer, J.-D. Abraham, A. Bohbot, F. Stoll-Keller, et al.. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2008, 32 (1), pp.59-68. ⟨10.1016/j.gcb.2007.12.006⟩. ⟨hal-02014496⟩
  • F. Schramm, R. Moenne-Loccoz, S. Fafi-Kremer, E. Soulier, C. Royer, et al.. Étude du leucotropisme du virus de l’hépatite C par analyse des quasi-espèces virales dans le contexte de la transplantation hépatique. Pathologie Biologie, 2008, 56 (7-8), pp.487-491. ⟨10.1016/j.patbio.2008.07.007⟩. ⟨hal-02014484⟩
  • Evelyne Schvoerer, Eric Soulier, Cathy Royer, Anne-Catherine Renaudin, Christine Thumann, et al.. Early Evolution of Hepatitis C Virus (HCV) Quasispecies after Liver Transplant for HCV‐Related Disease. Journal of Infectious Diseases, 2007, 196 (4), pp.528-536. ⟨10.1086/519691⟩. ⟨hal-02014515⟩
  • Mirjam B. Zeisel, George Koutsoudakis, Eva K. Schnober, Anita Haberstroh, Hubert E. Blum, et al.. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.. Hepatology, Wiley-Blackwell, 2007, 46 (6), pp.1722-31. ⟨10.1002/hep.21994⟩. ⟨inserm-00395706⟩
  • Evelyne Schvoerer, Christine Thumann, Stephan Spohrer, Eric Soulier, Cathy Royer, et al.. Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence. Journal of Medical Virology, 2006, 78 (8), pp.1070-1075. ⟨10.1002/jmv.20664⟩. ⟨hal-02014530⟩
  • Pierre Zachary, Marie-Josée Wendling, Saadi Djeddi, Evelyne Schvoerer, Murielle Ullmann, et al.. Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2006, 30 (12), pp.1419-20. ⟨hal-02014519⟩
  • Evelyne Schvoerer, Valéry Frechin, S Fritsch, R Freitag, A. Fuchs, et al.. Atypical symptoms in patients with herpesvirus DNA detected by PCR in cerebrospinal fluid. Journal of Clinical Virology, 2006, 35 (4), pp.458-462. ⟨10.1016/j.jcv.2005.11.005⟩. ⟨hal-02014535⟩
  • Evelyne Schvoerer, C. Thumann, E. Soulier, C. Royer, S. Fafi-Kremer, et al.. Récurrence de l'infection par le virus de l'hépatite C (VHC) après transplantation du foie pour hépatopathie due au VHC : facteurs liés à l'hôte et facteurs viraux impliqués dans la survenue et la gravité de la récurrence de l'hépatite virale C. Pathologie Biologie, 2006, 54 (10), pp.556-560. ⟨10.1016/j.patbio.2006.07.027⟩. ⟨hal-02014523⟩
  • Evelyne Schvoerer, Sylvie Henriot, Pierre Zachary, Rachel Freitag, Anne Fuchs, et al.. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. Journal of Medical Virology, 2005, 76 (1), pp.76-81. ⟨10.1002/jmv.20326⟩. ⟨hal-02014550⟩
  • Pierre Zachary, Murielle Ullmann, Saadi Djeddi, Nicolas Meyer, Marie-Josée Wendling, et al.. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. Journal of Clinical Virology, 2005, 34 (3), pp.207-210. ⟨10.1016/j.jcv.2005.06.005⟩. ⟨hal-02014543⟩
  • P. Zachary, M. Ullmann, Marie-Josée Wendling, S. Djeddi, Evelyne Schvoerer, et al.. Intérêt de l’immunoblot dans l’évaluation du statut sérologique vis-à-vis de l’hépatite C. Pathologie Biologie, 2004, 52 (9), pp.517-521. ⟨10.1016/j.patbio.2004.07.024⟩. ⟨hal-02014552⟩
  • Françoise Stoll-Keller, Evelyne Schvoerer, Christine Thumann, Maria-Cristina Navas, Anne-Marie Aubertin. Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches. Bulletin de l'Académie Nationale de Médecine, 2003, 187 (6), pp.1147-60; discussion 1160-1. ⟨hal-02014557⟩
  • Evelyne Schvoerer, M.C. Navas, C. Thumann, A. Fuchs, N. Meyer, et al.. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy. Journal of Medical Virology, 2003, 70 (4), pp.588-593. ⟨10.1002/jmv.10434⟩. ⟨hal-02014570⟩
  • Thomas Bourlet, Rachel Levy, Silvy Laporte, Stéphane Blachier, Laurence Bocket, et al.. Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.. Journal of Clinical Microbiology, 2003, 41 (2), pp.789-93. ⟨10.1128/JCM.41.2.789-793.2003⟩. ⟨hal-02014576⟩
  • Evelyne Schvoerer, Valéry Frechin, André Warter, Bernard Gasser, Hervé Jouin, et al.. Persistent multiple pulmonary nodules in a nonimmunocompromised woman after varicella-related myelitis treated with acyclovir.. Journal of Clinical Microbiology, 2003, 41 (10), pp.4904-5. ⟨10.1128/JCM.41.10.4904-4905.2003⟩. ⟨hal-02014563⟩
  • Evelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, Anne-Christine Jouvencel, Charles Balabaud, et al.. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2002, 26 (1), pp.62-6. ⟨hal-02014614⟩
  • Maria-Cristina Navas, Anne Fuchs, Evelyne Schvoerer, Alain Bohbot, Anne-Marie Aubertin, et al.. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. Journal of Medical Virology, 2002, 67 (2), pp.152-161. ⟨10.1002/jmv.2204⟩. ⟨hal-02014601⟩
  • Elisabeth Legrand, Didier Neau, Tatiana Galpérine, Pascale Trimoulet, Jean-François Moreau, et al.. CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment. Journal of Infectious Diseases, 2002, 186 (3), pp.302-311. ⟨10.1086/341659⟩. ⟨hal-02014584⟩
  • Evelyne Schvoerer, F. Stoll-Keller. Utilisation des tests commercialisés pour le diagnostic d'une infection à CMV chez les greffés de moelle et d'organe. Annales de Biologie Clinique, 2002, 60 (4), pp.463-7. ⟨hal-02043749⟩
  • P. Trimoulet, D. Neau, B. Le Bail, A. Rullier, M. Winnock, et al.. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. Journal of Medical Virology, 2002, 67 (2), pp.143-151. ⟨10.1002/jmv.2203⟩. ⟨hal-02014607⟩
  • Didier Neau, P. Trimoulet, M Winnock, B. Le Bail, Evelyne Schvoerer, et al.. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.. AIDS, 2001, 15 (13), pp.1736-8. ⟨hal-02014623⟩
  • Anne Caumont, Nguyen Thi Hoang Lan, Nguyen Thi Vy Uyen, Pham Van Hung, Evelyne Schvoerer, et al.. Sequence Analysis of env C2/V3, gag p17/p24, and pol Protease Regions of 25 HIV Type 1 Isolates from Ho Chi Minh City, Vietnam. AIDS Research and Human Retroviruses, 2001, 17 (13), pp.1285-1291. ⟨10.1089/088922201750461357⟩. ⟨hal-02014617⟩
  • Evelyne Schvoerer, M Ventura, O Dubos, G Cazaux, R Serceau, et al.. Qualitative and quantitative molecular detection of enteroviruses in water from bathing areas and from a sewage treatment plant.. Research in Microbiology, 2001, 152 (2), pp.179-86. ⟨10.1016/S0923-2508(01)01190-1⟩. ⟨hal-02014629⟩
  • Evelyne Schvoerer, F. Bonnet, V. Dubois, G Cazaux, R Serceau, et al.. PCR detection of human enteric viruses in bathing areas, waste waters and human stools in Southwestern France.. Research in Microbiology, 2000, 151 (8), pp.693-701. ⟨10.1016/S0923-2508(00)90132-3⟩. ⟨hal-02014634⟩
  • D. Neau, Evelyne Schvoerer, D. Robert, F. Dubois, H. Dutronc, et al.. Hepatitis B Exacerbation with a Precore Mutant Virus Following Withdrawal of Lamivudine in a Human Immunodeficiency Virus-infected Patient. Journal of Infection, 2000, 41 (2), pp.192-194. ⟨10.1053/jinf.2000.0724⟩. ⟨hal-02014644⟩
  • Evelyne Schvoerer, F. Bonnet, V. Dubois, M Rogues, J.-P. Gachie, et al.. A hospital outbreak of gastroenteritis possibly related to the contamination of tap water by a small round structured virus.. Journal of Hospital Infection, 1999, 43 (2), pp.149-154. ⟨10.1053/jhin.1999.0632⟩. ⟨hal-02014649⟩

Conference papers1 document

  • Honorine Fenaux, Manon Chassaing, Sibel Berger, H. Jeulin, Mouni Bensenane, et al.. Hepatitis E virus emergence in north eastern France. 20th Annual Meeting of the European Society for Clinical Virology, 2017, Stresa, Italy. ⟨hal-02111074⟩

Conference poster1 document

  • M. Faivre, V. Cottet, Jb. Bour, C. Richou, S. Valmary-Degano, et al.. Impact of Cytomegalovirus infection on the outcome of patients with cirrhosis: a preliminary study . International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. , Journal of Hepatology 66 (1, supplement), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. ⟨10.1016/S0168-8278(17)31534-9⟩. ⟨hal-01665366⟩

Preprints, Working Papers, ...1 document

  • Anne Gégout-Petit, Hélène Jeulin, Karine Legrand, Agathe Bochnakian, Pierre Vallois, et al.. Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. 2021. ⟨hal-03269203⟩